Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02850029
Other study ID # IRB 15 04 08
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 21, 2016
Est. completion date December 31, 2017

Study information

Verified date January 2019
Source Centre Hospitalier Universitaire de Nimes
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is an international observational cohort study on current aminoglycoside practices in intensive care units. Clinical and demographic data, dosing and therapeutic drug monitoring data will be collected during the first week of aminoglycoside (tobramycin, amikacin or gentamicin) administration in different countries over a year. A minimum of ten consecutive patients will be enrolled at each site.


Description:

Aminoglycosides are commonly used antibiotics for difficult to treat infections. However, aminoglycoside administration varies widely among countries. The aim of this multicenter observational study is to provide up-to-date and comprehensive descriptive data on current aminoglycoside (tobramycin, amikacin or gentamicin) use in a large cohort of critically ill patients in different countries. The benefits expected from this study are a better understanding of worldwide aminoglycoside prescription variability in critically ill patients and to determine the risk factors of inadequate aminoglycoside dosing regimens.


Recruitment information / eligibility

Status Completed
Enrollment 964
Est. completion date December 31, 2017
Est. primary completion date December 31, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age = 18 years old

- Intensive care unit patients

- Receiving aminoglycoside therapy for a sepsis according to the Third International Consensus Definitions for Sepsis and Septic Shock

Exclusion Criteria:

- Aged < 18 years of age

- Previous inclusion in the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Observational study, no intervention


Locations

Country Name City State
Australia Royal Brisbane and Women's Hospital Brisbane
Australia Royal Brisbane Women's Hospital Brisbane Queensland
Australia Frankston Hospital Victoria Frankston
Australia Sunshine Coast hospital Sunshine Coast
Australia Toowoomba Hospital Toowoomba
Chile Hospital Barros Luco Trudeau Santiago
Chile Hospital CU Chile Santiago
Chile Salvador Santiago Hospital Santiago
Chile Hospital Base de Valvidia Valdivia Region DE LOS RIOS
France Centre Hospitalier Aix-En-Provence Aix-en-provence
France Centre Hospitalier D'Ales Ales
France Chu Amiens Amiens
France Chu Angers Angers
France Chu Angers Angers
France Centre Hospitalier Arles Arles
France CHI Robert Ballanger Aulnay-sous-Bois
France Centre Hospitalier Aurillac Aurillac
France Centre Hospitalier Avignon Avignon
France Chru Besancon Besançon
France Chu Bordeaux Bordeaux
France Centre Hospitalier de BOULOGNE SUR MER Boulogne sur mer
France Centre Hospitalier Bourg En Bresse Bourg En Bresse
France Chru Brest Brest
France Chu Brest- Hopital Cavale Brest
France CHU CAEN Caen
France Centre Hospitalier Charleville-Mezieres Charleville-mezieres
France Chu Clermont-Ferrand Clermont-ferrand
France Centre Hospitalier de Compiegne Compiegne
France Chu Grenoble Grenoble
France Centre Hospitalier La Rochelle-Hopital Saint Louis La Rochelle
France Centre Hospitalier du Mans Le Mans
France Chu Lyon- Hopital La Croix Rousse Lyon
France Chu Lyon- Lyon Sud Lyon
France AP-HM - Hopital Nord Marseille
France APHM La timone Marseille Paca
France Aphm- La Conception Marseille
France Centre Hospitalier Sambre-Avesnois Maubeuge
France Centre Hospitalier de Montauban Montauban
France CHU MONTPELLIER-Hopital Lapeyronnie Montpellier
France CHU MONTPELLIER-Hopital St Eloi Montpellier
France Centre Hospitalier de MORLAIX Morlaix
France Chru Nancy -Hopital de Brabois Nancy
France Chu Nantes- Hopital Hotel Dieu Nantes
France CHU NANTES- hôpital Nord Laennec Nantes
France CHU Nice- Hopital Pasteur Nice
France CHU Nice-Hopital L'Archet Nice
France Centre Universitaire de Nimes Nimes
France AP-HP - Bicetre Paris
France AP-HP - Hopital Paris St Antoine Paris
France AP-HP - Paris St Louis Paris
France Aphp - Pitie Salpetriere Paris
France APHP- Bichat Paris
France APHP- Descartes Paris
France Aphp- Pitie Salpetriere Paris
France APHP-Hopital Georges Pompidou Paris
France Centre Hospitalier de PAU PAU
France Chu Poitiers Poitiers
France CHU REIMS- Hopital Robert Debré Reims
France CHU RENNES - Hopital Pontchaillou Rennes
France Centre Hospitalier de Roanne Roanne
France Centre Hospitalier de Rodez Rodez
France CHU ROUEN- Hopital Nicolle Rouen
France Centre Hospitalier Sainte Catherine Saint Brieuc
France CHU La Reunion-Hopital Felix Guyon Saint Denis
France CHU SAINT-ETIENNE - Hopital Nord Saint-etienne
France Centre Hospitalier de Salon de Provence Salon de Provence
France Centre Hospitalier Sainte Catherine Saverne
France Centre Hospitalier de Toulon, Hopital Sainte Musse Toulon
France CHU TOULOUSE- Hopital Rangueil Toulouse
France Centre Hospitalier Valence Valence
France Centre Hospitalier de Valenciennes Valenciennes
Greece Athens Hippocratio Hospital Athens
Greece Naval and Veterans Hospital of Athens Athens
Greece University Critical Care Department Aghioi Anargyroi Hospital Athens
Greece University Hospital of loannina Ioánnina
Greece G. Gennimatas General Hospital Thessaloníki
United Kingdom Sandwell and west Birmingham hospital Birmingham
United Kingdom University Hospital Birmingham Birmingham
United Kingdom Guy'S and St Thomas' London
United Kingdom Salford royal Manchester
United Kingdom University Hospital of South Manchester Manchester
United Kingdom Oxford Radcliffe Hospitals Oxford
United Kingdom St Helens and Knowsley Hospitals Prescot
United Kingdom Sheffield Teaching Hospitals Sheffield
United Kingdom Southampton University Hospitals Southampton

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Countries where clinical trial is conducted

Australia,  Chile,  France,  Greece,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Aminoglycoside current practices descriptive data in intensive care units Seven first days of aminoglycoside therapy
Secondary Aminoglycoside dosing regimens Seven first days of aminoglycoside therapy
Secondary Aminoglycoside therapy duration Seven first days of aminoglycoside therapy
Secondary Aminoglycoside therapeutic drug monitoring Seven first days of aminoglycoside therapy
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT06037928 - Plasma Sodium and Sodium Administration in the ICU
Completed NCT03671447 - Enhanced Recovery After Intensive Care (ERIC) N/A
Recruiting NCT03941002 - Continuous Evaluation of Diaphragm Function N/A
Recruiting NCT04674657 - Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
Completed NCT04239209 - Effect of Intensivist Communication on Surrogate Prognosis Interpretation N/A
Completed NCT05531305 - Longitudinal Changes in Muscle Mass After Intensive Care N/A
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Completed NCT02916004 - The Use of Nociception Flexion Reflex and Pupillary Dilatation Reflex in ICU Patients. N/A
Recruiting NCT05883137 - High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
Completed NCT04479254 - The Impact of IC-Guided Feeding Protocol on Clinical Outcomes in Critically Ill Patients (The IC-Study) N/A
Recruiting NCT04475666 - Replacing Protein Via Enteral Nutrition in Critically Ill Patients N/A
Not yet recruiting NCT04516395 - Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Withdrawn NCT04043091 - Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction N/A
Recruiting NCT02922998 - CD64 and Antibiotics in Human Sepsis N/A
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Completed NCT03048487 - Protein Consumption in Critically Ill Patients
Completed NCT02899208 - Can an Actigraph be Used to Predict Physical Function in Intensive Care Patients? N/A
Recruiting NCT02163109 - Oxygen Consumption in Critical Illness